Drug profile · INN
telmisartan
ACTELSAR HCT
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
telmisartan (ACTELSAR HCT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN telmisartan
Brand ACTELSAR HCT
Route ORAL
Formulation TABLET
ATC code C09DA07
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is telmisartan?
telmisartan (ACTELSAR HCT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for telmisartan?
ACTELSAR HCT is a marketed brand name for telmisartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of telmisartan?
telmisartan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.